MedTrace Logo

Evaluation of Cicaplast in Subjects With Skin Irritation

NCT05767333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2023-03-14

No results posted yet for this study

Summary

The aim of this open, before/after, multicentric study is to assess the effect and tolerance of Cicaplast Baume B5 in patients having a skin irritation (irritative and cracked dermatitis, dry eczematids, rubbing irritation, ...) under dermatological control. Patients are asked to apply the product at least twice a day until complete recovery (maximum 21 days).

Conditions

  • Skin Diseases

Sponsors & Collaborators

  • Cosmetique Active International

    lead INDUSTRY

Principal Investigators

  • Caroline Le Floc'h · Cosmetique Active International

Eligibility

Min Age
3 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2022-06-06
Completion
2022-06-06

Countries

  • United States
  • China
  • Mauritius
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05767333 on ClinicalTrials.gov